# Cumberland Pharmaceuticals Inc: Form 8-K, filed Apr 24, 2026

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2026-04-24
- Accepted by EDGAR: Apr 24, 2026, 17:08 ET
- Period: 2026-04-21
- Accession: 0001087294-26-000043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000043/cpix-20260421.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000043/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000108729426000043/cpix-20260421.htm

Filed Apr 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001087294-26-000043. Last ingested by Listed: Nov 14, 2026, 23:39 ET. No prices; not investment advice.
